BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu JC, Chan FK, Ching JY, Leung WK, Hui Y, Leong R, Chung SC, Sung JJ. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004;53:174-9. [PMID: 14724146 DOI: 10.1136/gut.2003.012641] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Goh KL. Gastroesophageal reflux disease in Asia: A historical perspective and present challenges. J Gastroenterol Hepatol. 2011;26 Suppl 1:2-10. [PMID: 21199509 DOI: 10.1111/j.1440-1746.2010.06534.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
2 Jensen RT. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol. 2006;98:4-19. [PMID: 16433886 DOI: 10.1111/j.1742-7843.2006.pto_378.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
3 Wipff J, Allanore Y, Soussi F, Terris B, Abitbol V, Raymond J, Chaussade S, Kahan A. Prevalence of Barrett’s esophagus in systemic sclerosis. Arthritis Rheum. 2005;52:2882-2888. [PMID: 16142744 DOI: 10.1002/art.21261] [Cited by in Crossref: 77] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
4 Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol. 2010;105:2153-2162. [PMID: 20571493 DOI: 10.1038/ajg.2010.251] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
5 Yucel O. Interactions between Helicobacter pylori and gastroesophageal reflux disease. Esophagus 2019;16:52-62. [PMID: 30151653 DOI: 10.1007/s10388-018-0637-5] [Reference Citation Analysis]
6 Calvet X. [Helicobacter pylori eradication treatment in non-ulcerous disease]. Gastroenterol Hepatol. 2005;28:40-46. [PMID: 15691468 DOI: 10.1157/13070383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
7 Kuipers EJ, Malfertheiner P. Helicobacter pylori and Nonmalignant Diseases. Helicobacter 2004;9:29-34. [DOI: 10.1111/j.1083-4389.2004.00247.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
8 Parente FR, Bargiggia SA, Anderloni A. Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: A liaison dangereuse or an innocent interplay? Scandinavian Journal of Gastroenterology 2009;41:1121-5. [DOI: 10.1080/00365520600931584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Iijima K, Koike T, Abe Y, Ara N, Uno K, Imatani A, Ohara S, Shimosegawa T. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. J Gastroenterol 2009;44:819-25. [DOI: 10.1007/s00535-009-0066-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
10 You JHS, Wong P, Wu JCY. Cost-effectiveness of Helicobacter pylori “test and treat” for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: A Markov model analysis. Scandinavian Journal of Gastroenterology 2009;41:21-9. [DOI: 10.1080/00365520510023873] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
11 Maguire A, Sheahan K. Pathology of oesophagitis: Pathology of oesophagitis. Histopathology 2012;60:864-79. [DOI: 10.1111/j.1365-2559.2011.03855.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
12 Tan HJ, Goh KL. Changing epidemiology of Helicobacter pylori in Asia. J Dig Dis. 2008;9:186-189. [PMID: 18959588 DOI: 10.1111/j.1751-2980.2008.00344.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kupcinskas L, Malfertheiner P. Helicobacter pylori and Non-malignant Diseases. Helicobacter 2005;10:26-33. [DOI: 10.1111/j.1523-5378.2005.00340.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
14 Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao S, Tan HJ, Wu C, Jung HC, Hoang BH, Kachintorn U, Goh K, Chiba T, Rani AA. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2009;24:1587-600. [DOI: 10.1111/j.1440-1746.2009.05982.x] [Cited by in Crossref: 357] [Cited by in F6Publishing: 353] [Article Influence: 27.5] [Reference Citation Analysis]
15 Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchôa DM, Francesconi CF, Prolla JC. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Aliment Pharmacol Ther 2005;21:1231-9. [PMID: 15882244 DOI: 10.1111/j.1365-2036.2005.02461.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
16 Wu JC. Gastroesophageal reflux disease: an Asian perspective. J Gastroenterol Hepatol. 2008;23:1785-1793. [PMID: 19120871 DOI: 10.1111/j.1440-1746.2008.05684.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
17 Guarner J. The spectrum of gastric disease associated with Helicobacter pylori and other infectious gastritides. Curr Gastroenterol Rep 2004;6:441-6. [PMID: 15527673 DOI: 10.1007/s11894-004-0065-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
18 Gisbert JP, Piqué JM. Indicaciones y consecuencias de la erradicación de Helicobacter pylori en la enfermedad por reflujo gastroesofágico. Medicina Clínica 2005;124:697-709. [DOI: 10.1157/13075094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2012;47:129-135. [PMID: 22229305 DOI: 10.3109/00365521.2011.648955] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
20 Zhang YS, Zhang HR. Effect of Helicobacter pylori infection on gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi 2014; 22(27): 4107-4112 [DOI: 10.11569/wcjd.v22.i27.4107] [Reference Citation Analysis]
21 Hirata K, Suzuki H, Matsuzaki J, Masaoka T, Saito Y, Nishizawa T, Iwasaki E, Fukuhara S, Okada S, Hibi T. Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy. J Clin Biochem Nutr. 2013;52:172-178. [PMID: 23524980 DOI: 10.3164/jcbn.12-107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
22 Frazzoni M, Manno M, De Micheli E, Savarino V. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors. Digestive and Liver Disease 2007;39:415-21. [DOI: 10.1016/j.dld.2007.01.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
23 Nordenstedt H, Lagergren J. Environmental factors in the etiology of gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol. 2008;2:93-103. [PMID: 19072373 DOI: 10.1586/17474124.2.1.93] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
24 Moraes-filho JPP, Navarro-rodriguez T, Barbuti R, Eisig J, Chinzon D, Bernardo W. Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus. Arq Gastroenterol 2010;47:99-115. [DOI: 10.1590/s0004-28032010000100017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
25 Sugimoto M, Murata M, Mizuno H, Iwata E, Nagata N, Itoi T, Kawai T. Endoscopic Reflux Esophagitis and Reflux-Related Symptoms after Helicobacter pylori Eradication Therapy: Meta-Analysis. J Clin Med 2020;9:E3007. [PMID: 32961949 DOI: 10.3390/jcm9093007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Delaney B, McColl K. Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;22 Suppl 1:32-40. [PMID: 16042657 DOI: 10.1111/j.1365-2036.2005.02607.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
27 Goh KL, Benamouzig R, Sander P, Schwan T; EMANCIPATE. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study. Eur J Gastroenterol Hepatol 2007;19:205-11. [PMID: 17301646 DOI: 10.1097/MEG.0b013e32801055d5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
28 Gibson PG. How does azithromycin improve asthma exacerbations? - Author's reply. Lancet 2018;391:28-9. [PMID: 29323652 DOI: 10.1016/S0140-6736(17)33319-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Lai LH, Sung JJ. Helicobacter pylori and benign upper digestive disease. Best Practice & Research Clinical Gastroenterology 2007;21:261-79. [DOI: 10.1016/j.bpg.2006.10.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
30 Mou WL, Feng MY, Hu LH. Eradication of Helicobacter Pylori Infections and GERD: A systematic review and meta-analysis. Turk J Gastroenterol 2020;31:853-9. [PMID: 33625997 DOI: 10.5152/tjg.2020.19699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Sabbagh P, Javanian M, Koppolu V, Vasigala VR, Ebrahimpour S. Helicobacter pylori infection in children: an overview of diagnostic methods. Eur J Clin Microbiol Infect Dis 2019;38:1035-45. [PMID: 30734129 DOI: 10.1007/s10096-019-03502-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
32 Yucel O. Interactions between Helicobacter pylori and gastroesophageal reflux disease. Esophagus 2019;16:52-62. [PMID: 30151653 DOI: 10.1007/s10388-018-0637-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K; Japanese Society for Helicobacter Research. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1-20. [PMID: 20302585 DOI: 10.1111/j.1523-5378.2009.00738.x] [Cited by in Crossref: 262] [Cited by in F6Publishing: 241] [Article Influence: 21.8] [Reference Citation Analysis]
34 Malfertheiner P, Peitz U. The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia. Gut 2005;54 Suppl 1:i13-20. [PMID: 15711003 DOI: 10.1136/gut.2004.041533] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
35 Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, Yeoh KG, Hsu PI, Goh KL, Mahachai V, Gotoda T, Chang WL, Chen MJ, Chiang TH, Chen CC, Wu CY, Leow AH, Wu JY, Wu DC, Hong TC, Lu H, Yamaoka Y, Megraud F, Chan FKL, Sung JJ, Lin JT, Graham DY, Wu MS, El-Omar EM; Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut 2020;69:2093-112. [PMID: 33004546 DOI: 10.1136/gutjnl-2020-322368] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 35.0] [Reference Citation Analysis]
36 McColl KE. Helicobacter pylori and oesophageal cancer--not always protective. Gut 2007;56:457-9. [PMID: 17369378 DOI: 10.1136/gut.2006.111385] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
37 Al-Marhabi A, Hashem A, Zuberi BF, Onyekwere C, Lodhi I, Mounir M, Alkhowaiter S, Al Awadhi S, Naidoo VG, Hamada Y. The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD). Expert Rev Gastroenterol Hepatol 2022;16:217-33. [PMID: 35184616 DOI: 10.1080/17474124.2022.2043744] [Reference Citation Analysis]
38 Talebi Bezmin Abadi A. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017;8:123-30. [DOI: 10.1016/j.jgar.2016.11.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
39 Miyake K, Tatsuguchi A, Suzuki K, Ueki N, Shinji Y, Kusunoki M, Iizumi T, Hiratsuka T, Nishigaki H, Futagami S, Wada K, Tsukui T, Sakamoto C. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection. Digestive and Liver Disease 2005;37:394-401. [DOI: 10.1016/j.dld.2004.12.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
40 Cheung TK, Wong BC, Lam SK. Gastro-oesophageal reflux disease in Asia: birth of a ‘new’ disease? Drugs. 2008;68:399-406. [PMID: 18318559 DOI: 10.2165/00003495-200868040-00001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
41 Mihara T, Adachi K, Komazawa Y, Yoshida M, Araki A, Maruyama R, Furuta K, Ishihara S, Amano Y, Kinoshita Y. Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis: Esophagitis and H. pylori. Journal of Gastroenterology and Hepatology 2005;20:682-7. [DOI: 10.1111/j.1440-1746.2005.03779.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
42 Sabbi T, De Angelis P, Dall'Oglio L. Helicobacter pylori infection in children: management and pharmacotherapy. Expert Opin Pharmacother 2008;9:577-85. [PMID: 18312159 DOI: 10.1517/14656566.9.4.577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
43 Kuipers EJ. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes? Basic Clin Pharmacol Toxicol 2006;99:187-94. [PMID: 16930292 DOI: 10.1111/j.1742-7843.2006.pto_478.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
44 Calleja JL, Suarez M, De Tejada AH, Navarro A. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Dig Dis Sci. 2005;50:432-439. [PMID: 15810621 DOI: 10.1007/s10620-005-2453-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
45 Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3:1-10. [PMID: 15645398 DOI: 10.1016/s1542-3565(04)00602-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]